EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Aadi Bioscience's Enterprise Value is $-63.38 Mil.
Aadi Bioscience's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-65.53 Mil. Therefore, Aadi Bioscience's EV-to-EBIT for today is 0.97.
The historical rank and industry rank for Aadi Bioscience's EV-to-EBIT or its related term are showing as below:
AADI'
s EV-to-EBIT Range Over the Past 10 Years
Min: -684.43 Med: -1.1 Max: 1.03
Current: 0.97
During the past 4 years, the highest EV-to-EBIT of Aadi Bioscience was 1.03. The lowest was -684.43. And the median was -1.10.
AADI's EV-to-EBIT is ranked better than 67.5% of 440
companies
in the Biotechnology industry
Industry Median: 8.685
vs AADI: 0.97
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Aadi Bioscience's Enterprise Value for the quarter that ended in Dec. 2023 was $-57.98 Mil.
Aadi Bioscience's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-65.53 Mil. Aadi Bioscience's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 113.03%.
Aadi Bioscience EV-to-EBIT Historical Data
The historical data trend for Aadi Bioscience's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Aadi Bioscience Annual Data
Trend
Dec20
Dec21
Dec22
Dec23
EV-to-EBIT
-
-3.26
-2.37
0.88
Aadi Bioscience Quarterly Data
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
EV-to-EBIT
-2.37
-0.44
-0.56
-0.01
0.88
Competitive Comparison
For the Biotechnology subindustry, Aadi Bioscience's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aadi Bioscience EV-to-EBIT Distribution
For the Biotechnology industry and Healthcare sector, Aadi Bioscience's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Aadi Bioscience's EV-to-EBIT falls into.
Aadi Bioscience EV-to-EBIT Calculation
Aadi Bioscience's EV-to-EBIT for today is calculated as:
Aadi Bioscience's current Enterprise Value is $-63.38 Mil.
Aadi Bioscience's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-65.53 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aadi Bioscience (NAS:AADI) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Aadi Bioscience's Enterprise Value for the quarter that ended in Dec. 2023 was $-57.98 Mil.
Aadi Bioscience's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-65.53 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aadi Bioscience EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Aadi Bioscience's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Aadi Bioscience (Aadi Bioscience) Business Description
Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AADI has been successfully added to your 